ストックスクリーナーアプリを入手
2.33
10.43%
0.22
アフターアワーズ：
2.33
前日終値:
$2.11
開ける：
$2.13
24時間の取引高:
468.70K
Relative Volume:
3.61
時価総額：
$5.07M
収益：
$10.48M
当期純損益:
$-37.74M
株価収益率:
-0.144
EPS:
-16.1846
ネットキャッシュフロー:
$-29.03M
1週間 パフォーマンス:
+15.92%
1か月 パフォーマンス:
+42.94%
6か月 パフォーマンス:
-51.05%
1年 パフォーマンス:
-93.10%
1日の値動き範囲:
$2.01
$2.4399
1週間の範囲:
$1.91
$2.4399
52週間の値動き範囲:
$1.5701
$35.00
Jaguar Health Inc Stock (JAGX) Company Profile
名前
Jaguar Health Inc
セクター
電話
415-371-8300
住所
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
JAGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
2.33 | 4.59M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-07-11 | 開始されました | Rodman & Renshaw | Buy |
Jaguar Health Inc (JAGX) 最新ニュース
Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - The Des Moines Register
Jaguar Health at Lytham Partners: Strategic Insights on Crofelemer By Investing.com - Investing.com Canada
Jaguar Health provides drug for expanded access to treat rare disease - Investing.com India
FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease - Centre Daily Times
27% TPN Reduction: Jaguar Health's Crofelemer Shows Promise in Ultra-Rare MVID Disease Treatment - Stock Titan
Is Jaguar Health Inc a good long term investmentBollinger Bands Signals & Affordable Market Strategies - earlytimes.in
Can technical indicators confirm Jaguar Health Inc.’s reversal2025 Short Interest & High Return Trade Guides - newser.com
Price action breakdown for Jaguar Health Inc.Trade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Is Jaguar Health Inc. stock a buy before product launchesCEO Change & Weekly Watchlist for Hot Stocks - newser.com
Will Jaguar Health Inc. outperform the market2025 Top Gainers & Technical Pattern Based Signals - newser.com
Detecting price anomalies in Jaguar Health Inc. with AISell Signal & Expert Approved Trade Ideas - newser.com
Why Institutions Believe Lotus Eye Hospital and Institute Limited Is Undervalued TodayValue Traps to Avoid & Explosive Capital Gains - earlytimes.in
What analysts say about Jaguar Health Inc 1JA0 stockTechnical Breakout Signals & Discover Stocks Experts Are Watching - earlytimes.in
Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Norwich Bulletin
Jaguar Health : Corporate Presentation – September 26, 2025 (ba7a24) - MarketScreener
Jaguar Health at Emerging Growth Conference: Strategic Path to Growth By Investing.com - Investing.com Canada
Jaguar Health Completes Private Placement Deal - MSN
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts - Livingston Daily
Jaguar Health (JAGX) Secures FDA Grant for Canalevia Study - GuruFocus
Jaguar Health receives $250,000 FDA grant for canine diarrhea drug study - Investing.com India
$250,000 FDA Grant Advances Treatment for Cancer Dogs: Jaguar Health's Canalevia Targets 11M Pet Market - Stock Titan
Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition - Lexington Herald Leader
Novel Diarrhea Drug Could Help Breast Cancer Patients: Jaguar Health Pursues Special FDA Status - Stock Titan
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Tacoma News Tribune
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts | FinancialContent - FinancialContent
12 Best Fundamentally Strong Penny Stocks to Buy Right Now - Insider Monkey
Sectors Review: What is Jaguar Health Incs revenue forecast2025 Support & Resistance & Technical Pattern Based Signals - خودرو بانک
Published on: 2025-09-19 12:18:16 - خودرو بانک
Momentum Shift: Is Jaguar Health Inc undervalued by DCF analysisM&A Rumor & High Accuracy Swing Entry Alerts - خودرو بانک
Death Cross: Should I buy Jaguar Health Inc stock now2025 Technical Patterns & Daily Oversold Stock Bounce Ideas - khodrobank.com
Winners Losers: Will Jaguar Health Inc benefit from current market trendsWeekly Trade Recap & Precise Swing Trade Entry Alerts - خودرو بانک
Aug PreEarnings: Is Magic Empire Global Limited a strong candidate for buy and holdOptions Play & AI Forecasted Stock Moves - خودرو بانک
Sentiment Watch: Is Jaguar Health Inc. on track to beat earnings2025 Risk Factors & Precise Buy Zone Identification - خودرو بانک
Aug Momentum: Will Jaguar Health Inc outperform the market in YEARWatch List & Safe Swing Trade Setup Alerts - خودرو بانک
Portfolio Shifts: Will Jaguar Health Inc outperform the market in YEARWeekly Trade Analysis & Consistent Return Investment Signals - خودرو بانک
Buyout Rumor: What makes LANC stock attractive todayMarket Sentiment Summary & Expert Verified Stock Movement Alerts - خودرو بانک
Can volume confirm reversal in Jaguar Health Inc.2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
Aug PreEarnings: Should I add Jaguar Health Inc. stock to my portfolioTrade Signal Summary & Daily Stock Trend Watchlist - khodrobank.com
Aug Intraday: Does Jaguar Health Inc stock benefit from AI growth2025 Price Targets & Weekly High Potential Alerts - خودرو بانک
What are Jaguar Health Inc.’s recent SEC filings showingJuly 2025 Setups & Community Verified Swing Trade Signals - خودرو بانک
Will Jaguar Health Inc. bounce back from current supportShare Buyback & Verified Momentum Stock Watchlist - newser.com
Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia’s Indication to Treatment of General Diarrhea in Dogs - The Marion Star
Trend Report: Will PAYC stock benefit from M&ATrade Volume Report & Entry Point Confirmation Signals - خودرو بانک
Jaguar Animal Health Completes Private Placement of Preferred Stock - MSN
Is Jaguar Health Inc. likely to announce a buybackEarnings Beat & Reliable Intraday Trade Plans - Lancaster City Council
Is Jaguar Health Inc. on track to beat earnings2025 Top Gainers & Risk Controlled Stock Alerts - Lancaster City Council
Jaguar Health Inc (JAGX) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):